Fisher Owain, Meecham Lewis, Buxton Pauline, Legge Jocelyn, Fairhead Jack, Rajagopalan Sriram, Asquith John, Pherwani Arun
1 Department of Vascular Surgery, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
2 Department of Renal Medicine, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
J Vasc Access. 2018 Nov;19(6):658-662. doi: 10.1177/1129729818769795. Epub 2018 Apr 12.
: Stenosis of an arteriovenous fistula or arteriovenous graft for dialysis is a common problem. Stenosis may lead to a number of problems including failure of the fistula. Treatment of stenosis is commonly with percutaneous angioplasty or surgical patch angioplasty with autologous vein or synthetic graft or patch. Here we report the use of bovine pericardial patch angioplasty as an alternative mode of patch angioplasty when percutaneous intervention has failed.
: Patients with fistulae treated with bovine patch angioplasty between 2013 and 2016 were identified from a prospectively maintained renal access database (Cyberren). Patient records were reviewed, noting type and location of access, patency, re-interventions and complications post bovine pericardial patch.
: A total of 40 patients were identified as having undergone bovine pericardial patch angioplasty between January 2013 and April 2016. The median time from fistula formation to bovine pericardial patch was 15 months (interquartile range (IQR): 5-43). Median duration of follow-up was 14 months (IQR: 5-18). Primary patency at 6, 12, 18 and 24 months was 91%, 66%, 61% and 54%, respectively. Secondary patency was 94%, 91%, 80% and 77% at the same time points, respectively. In total, 15 patients required 23 re-interventions post bovine pericardial patch. There has been no report of infection or aneurysm formation.
: Bovine pericardial patch angioplasty for recurrent stenosis in arteriovenous fistulae for dialysis access provides a robust alternative to other surgical patches with the added advantage of allowing early needling and relative resistance to infection. Rates of restenosis and failure post bovine pericardial patch are low.
动静脉内瘘或动静脉移植物用于透析时发生狭窄是一个常见问题。狭窄可能导致多种问题,包括内瘘失功。狭窄的治疗通常采用经皮血管成形术或使用自体静脉、合成移植物或补片进行手术补片血管成形术。在此,我们报告当经皮干预失败时,使用牛心包补片血管成形术作为补片血管成形术的一种替代方式。
从一个前瞻性维护的肾脏通路数据库(Cyberren)中识别出2013年至2016年间接受牛心包补片血管成形术治疗的内瘘患者。回顾患者记录,记录通路的类型和位置、通畅情况、再次干预以及牛心包补片置入后的并发症。
共识别出40例在2013年1月至2016年4月期间接受牛心包补片血管成形术的患者。从内瘘形成到进行牛心包补片的中位时间为15个月(四分位间距(IQR):5 - 43)。中位随访时间为14个月(IQR:5 - 18)。6个月、12个月、18个月和24个月时的初次通畅率分别为91%、66%、61%和54%。在相同时间点,二次通畅率分别为94%、91%、80%和77%。总计,15例患者在牛心包补片置入后需要进行23次再次干预。未报告感染或动脉瘤形成的情况。
用于透析通路的动静脉内瘘复发性狭窄的牛心包补片血管成形术为其他手术补片提供了一种可靠的替代方法,具有允许早期穿刺和相对抗感染的额外优势。牛心包补片置入后的再狭窄率和失功率较低。